Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Melissa Angell
Articles From This Author
HEALTH
Why You Can Thank Millennials for the Booming $70 Billion Pet Industry
By Melissa Angell
Aug 8, 2017 5:14 PM EDT
HEALTH
Cramer: Every time I see Pfizer quarter, I recognize why they needed to do the Allergen deal
By Melissa Angell
Aug 7, 2017 12:13 PM EDT
HEALTH
Now That's a Switch: Longtime Tomato Grower to Fill Greenhouse With Weed
By Melissa Angell
Aug 5, 2017 1:40 PM EDT
HEALTH
$AGN posted $4 billion in revenue in the aesthetics division
By Melissa Angell
Aug 3, 2017 3:15 PM EDT
OPINION
Here's How You Can Score a Free Burrito
By Melissa Angell
Aug 3, 2017 2:57 PM EDT
HEALTH
Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe
By Melissa Angell
Aug 1, 2017 2:33 PM EDT
INVESTING
Billionaire Mark Cuban: The Rise of Technology Will Cause a Lot of Unemployment
By Melissa Angell
Jul 31, 2017 4:43 PM EDT
HEALTH
The Pharma Giant Reports its Earnings Tomorrow Morning.
By Melissa Angell
Jul 31, 2017 4:03 PM EDT
HEALTH
Teamsters Wary of McKesson's Promise to Split Top Roles
By Melissa Angell
Jul 27, 2017 5:59 PM EDT
HEALTH
Now, You Can Buy Shares of Popular Pro-Pot Periodical High Times
By Melissa Angell
Jul 27, 2017 3:59 PM EDT
MERGERS AND ACQUISITIONS
The "vote no" campaign led by the International Brotherhood of Teamsters against $MCK succeeds
By Melissa Angell
Jul 27, 2017 8:04 AM EDT
MERGERS AND ACQUISITIONS
Hospital Operators Sink Amid Healthcare Confusion
By Melissa Angell
Jul 25, 2017 3:04 PM EDT
HEALTH
Teamsters to Protest McKesson's Shareholder Meeting Wednesday
By Melissa Angell
Jul 24, 2017 4:57 PM EDT
HEALTH
Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day
By Melissa Angell
Jul 21, 2017 12:26 PM EDT
HEALTH
Kala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep Coming
By Melissa Angell
Jul 20, 2017 11:36 AM EDT
HEALTH
Some Analysts Predict Revenue to Triple
By Melissa Angell
Jul 19, 2017 1:04 PM EDT
BANKRUPTCY
Valeant is working to repay some $30 billion in debt.
By Melissa Angell
Jul 17, 2017 6:20 PM EDT
STOCKS
Konica and Ambry Pairing to Accelerate Precision Medicine
By Melissa Angell
Jul 15, 2017 10:40 AM EDT
MERGERS AND ACQUISITIONS
Konica and Ambry Pairing to Accelerate Precision Medicine
By Melissa Angell
Jul 14, 2017 5:24 PM EDT
STOCKS
Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health
By Melissa Angell
Jul 13, 2017 11:38 AM EDT
HEALTH
Move Over GMO's: IPO for Gene Editor Calyxt Launches Next Week
By Melissa Angell
Jul 10, 2017 5:09 PM EDT
STOCKS
Bristol Myers vies to be king of immune-boosting cancer drugs with new trial update
By Melissa Angell
Jul 9, 2017 8:38 PM EDT
HEALTH
Alexion Can't Stay Out of the Spotlight
By Melissa Angell
Jul 7, 2017 4:35 PM EDT
HEALTH
Celgene Enters PD1 Market with BeiGene Deal
By Melissa Angell
Jul 6, 2017 4:42 PM EDT
HEALTH
Pfizer has left the building
By Melissa Angell
Jul 6, 2017 4:14 PM EDT
STOCKS
Here's the Latest on Four New Biotech IPOs
By Melissa Angell
Jul 3, 2017 1:02 PM EDT
HEALTH
"There is no longer any cash at the fund level" Shkreli wrote to his investors.
By Melissa Angell
Jun 30, 2017 3:07 PM EDT
STOCKS
Could an exhaustive juror search be part of the Pharma Bro's master plan?
By Melissa Angell
Jun 28, 2017 3:46 PM EDT
CORPORATE GOVERNANCE
Shkreli's Lawyer Attempts to Ban Press...Again
By Melissa Angell
Jun 27, 2017 12:13 PM EDT
HEALTH
The jury selection process for Shkreli's trial got underway Monday and is expected to continue Tues.
By Melissa Angell
Jun 26, 2017 6:39 PM EDT
HEALTH
Pharma Bro's Trial to Begin Today
By Melissa Angell
Jun 26, 2017 10:14 AM EDT
HEALTH
Could Merck and Leap Union Be the One for Keytruda?
By Melissa Angell
Jun 24, 2017 5:00 PM EDT
HEALTH
Breaking Down the Senate Healthcare Bill
By Melissa Angell
Jun 22, 2017 6:16 PM EDT
HEALTH
Hey Big Pharma, Meet the Better Care Reconciliation Act
By Melissa Angell
Jun 22, 2017 12:19 PM EDT
STOCKS
FDA Commissioner Takes on Big Pharma
By Melissa Angell
Jun 21, 2017 5:17 PM EDT
HEALTH
Regeneron Soars After Eye Drug Competitor Novartis Releases Positive Data
By Melissa Angell
Jun 20, 2017 5:50 PM EDT
MERGERS AND ACQUISITIONS
Local NYC Grocers Unhappy with Amazon-Whole Foods Deal
By Melissa Angell
Jun 20, 2017 11:22 AM EDT
STOCKS
These products from Medical Marijuana are legal in all 50 states
By Melissa Angell
Jun 17, 2017 12:20 PM EDT
HEALTH
There's a new biotech fund out there... and it's got $300 million
By Melissa Angell
Jun 16, 2017 9:45 AM EDT
HEALTH
Epizyme's eventual rebound may show promise with results from cancer drug.
By Melissa Angell
Jun 15, 2017 4:10 PM EDT
HEALTH
AstraZeneca drops partnership with Regulus after ditching drug
By Melissa Angell
Jun 13, 2017 1:12 PM EDT
HEALTH
Who is next for TMO's insatiable M&A appetite?
By Melissa Angell
Jun 13, 2017 11:56 AM EDT
HEALTH
Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
By Melissa Angell
Jun 9, 2017 5:20 PM EDT
HEALTH
Here's the technology that big banks, doctors, and startups are all using
By Melissa Angell
Jun 7, 2017 4:49 PM EDT
HEALTH
Amgen Wants to Boost Label on Powerhouse Repatha
By Melissa Angell
Jun 7, 2017 4:46 PM EDT
HEALTH
Can healthcare giant Integra continue to grow? Signs point to yes.
By Melissa Angell
Jun 4, 2017 12:20 PM EDT
HEALTH
Community Health to Sell Hospitals in Pennsylvania
By Melissa Angell
May 30, 2017 6:38 PM EDT